The global Human DNA Vaccines market is projected to grow from US$ 4635.1 million in 2024 to US$ 5250.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.1% during the forecast period.

Human DNA Vaccines Market

DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunogenicity when compared to protein vaccines. A wide variety of strategies have been developed to optimize DNA vaccine immunogenicity, including codon optimization, genetic adjuvants, electroporation and sophisticated prime-boost regimens, with each of these methods having its advantages and limitations. Whilst each of these methods has contributed to incremental improvements in DNA vaccine efficacy, more is still needed if human DNA vaccines are to succeed commercially.

Market Analysis and Insights: Global Human DNA Vaccines Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Human DNA Vaccines market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Human DNA Vaccines, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human DNA Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human DNA Vaccines revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Human DNA Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Human DNA Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Human DNA Vaccines Market Report

Report Metric	Details
Report Name	Human DNA Vaccines Market
Accounted market size in 2024	US$ 4635.1 million
Forecasted market size in 2030	US$ 5250.7 million
CAGR	2.1
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Recombinant Protein Vaccine Gene-Based Vaccine
Segment by Application	Influenza Human Papillomavirus HIV
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Human DNA Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human DNA Vaccines companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human DNA Vaccines revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Human DNA Vaccines Market growing?

Ans: The Human DNA Vaccines Market witnessing a CAGR of 2.1 during the forecast period 2025-2030.

What is the Human DNA Vaccines Market size in 2030?

Ans: The Human DNA Vaccines Market size in 2030 will be US$ 5250.7 million.

Who are the main players in the Human DNA Vaccines Market report?

Ans: The main players in the Human DNA Vaccines Market are Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences

What are the Application segmentation covered in the Human DNA Vaccines Market report?

Ans: The Applications covered in the Human DNA Vaccines Market report are Influenza, Human Papillomavirus, HIV

What are the Type segmentation covered in the Human DNA Vaccines Market report?

Ans: The Types covered in the Human DNA Vaccines Market report are Recombinant Protein Vaccine, Gene-Based Vaccine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human DNA Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Recombinant Protein Vaccine

1.2.3 Gene-Based Vaccine

1.3 Market by Application

1.3.1 Global Human DNA Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Influenza

1.3.3 Human Papillomavirus

1.3.4 HIV

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human DNA Vaccines Market Perspective (2019-2030)

2.2 Global Human DNA Vaccines Growth Trends by Region

2.2.1 Human DNA Vaccines Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Human DNA Vaccines Historic Market Size by Region (2019-2024)

2.2.3 Human DNA Vaccines Forecasted Market Size by Region (2025-2030)

2.3 Human DNA Vaccines Market Dynamics

2.3.1 Human DNA Vaccines Industry Trends

2.3.2 Human DNA Vaccines Market Drivers

2.3.3 Human DNA Vaccines Market Challenges

2.3.4 Human DNA Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Human DNA Vaccines by Players

3.1.1 Global Human DNA Vaccines Revenue by Players (2019-2024)

3.1.2 Global Human DNA Vaccines Revenue Market Share by Players (2019-2024)

3.2 Global Human DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Human DNA Vaccines, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Human DNA Vaccines Market Concentration Ratio

3.4.1 Global Human DNA Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human DNA Vaccines Revenue in 2023

3.5 Global Key Players of Human DNA Vaccines Head office and Area Served

3.6 Global Key Players of Human DNA Vaccines, Product and Application

3.7 Global Key Players of Human DNA Vaccines, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Human DNA Vaccines Breakdown Data by Type

4.1 Global Human DNA Vaccines Historic Market Size by Type (2019-2024)

4.2 Global Human DNA Vaccines Forecasted Market Size by Type (2025-2030)

5 Human DNA Vaccines Breakdown Data by Application

5.1 Global Human DNA Vaccines Historic Market Size by Application (2019-2024)

5.2 Global Human DNA Vaccines Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Human DNA Vaccines Market Size (2019-2030)

6.2 North America Human DNA Vaccines Market Size by Type

6.2.1 North America Human DNA Vaccines Market Size by Type (2019-2024)

6.2.2 North America Human DNA Vaccines Market Size by Type (2025-2030)

6.2.3 North America Human DNA Vaccines Market Share by Type (2019-2030)

6.3 North America Human DNA Vaccines Market Size by Application

6.3.1 North America Human DNA Vaccines Market Size by Application (2019-2024)

6.3.2 North America Human DNA Vaccines Market Size by Application (2025-2030)

6.3.3 North America Human DNA Vaccines Market Share by Application (2019-2030)

6.4 North America Human DNA Vaccines Market Size by Country

6.4.1 North America Human DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Human DNA Vaccines Market Size by Country (2019-2024)

6.4.3 North America Human DNA Vaccines Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Human DNA Vaccines Market Size (2019-2030)

7.2 Europe Human DNA Vaccines Market Size by Type

7.2.1 Europe Human DNA Vaccines Market Size by Type (2019-2024)

7.2.2 Europe Human DNA Vaccines Market Size by Type (2025-2030)

7.2.3 Europe Human DNA Vaccines Market Share by Type (2019-2030)

7.3 Europe Human DNA Vaccines Market Size by Application

7.3.1 Europe Human DNA Vaccines Market Size by Application (2019-2024)

7.3.2 Europe Human DNA Vaccines Market Size by Application (2025-2030)

7.3.3 Europe Human DNA Vaccines Market Share by Application (2019-2030)

7.4 Europe Human DNA Vaccines Market Size by Country

7.4.1 Europe Human DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Human DNA Vaccines Market Size by Country (2019-2024)

7.4.3 Europe Human DNA Vaccines Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Human DNA Vaccines Market Size (2019-2030)

8.2 China Human DNA Vaccines Market Size by Type

8.2.1 China Human DNA Vaccines Market Size by Type (2019-2024)

8.2.2 China Human DNA Vaccines Market Size by Type (2025-2030)

8.2.3 China Human DNA Vaccines Market Share by Type (2019-2030)

8.3 China Human DNA Vaccines Market Size by Application

8.3.1 China Human DNA Vaccines Market Size by Application (2019-2024)

8.3.2 China Human DNA Vaccines Market Size by Application (2025-2030)

8.3.3 China Human DNA Vaccines Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Human DNA Vaccines Market Size (2019-2030)

9.2 Asia Human DNA Vaccines Market Size by Type

9.2.1 Asia Human DNA Vaccines Market Size by Type (2019-2024)

9.2.2 Asia Human DNA Vaccines Market Size by Type (2025-2030)

9.2.3 Asia Human DNA Vaccines Market Share by Type (2019-2030)

9.3 Asia Human DNA Vaccines Market Size by Application

9.3.1 Asia Human DNA Vaccines Market Size by Application (2019-2024)

9.3.2 Asia Human DNA Vaccines Market Size by Application (2025-2030)

9.3.3 Asia Human DNA Vaccines Market Share by Application (2019-2030)

9.4 Asia Human DNA Vaccines Market Size by Region

9.4.1 Asia Human DNA Vaccines Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Human DNA Vaccines Market Size by Region (2019-2024)

9.4.3 Asia Human DNA Vaccines Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Human DNA Vaccines Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Type

10.2.1 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Human DNA Vaccines Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Application

10.3.1 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Human DNA Vaccines Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Country

10.4.1 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Human DNA Vaccines Introduction

11.1.4 Merck Revenue in Human DNA Vaccines Business (2019-2024)

11.1.5 Merck Recent Developments

11.2 GSK

11.2.1 GSK Company Details

11.2.2 GSK Business Overview

11.2.3 GSK Human DNA Vaccines Introduction

11.2.4 GSK Revenue in Human DNA Vaccines Business (2019-2024)

11.2.5 GSK Recent Developments

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Human DNA Vaccines Introduction

11.3.4 Sanofi Revenue in Human DNA Vaccines Business (2019-2024)

11.3.5 Sanofi Recent Developments

11.4 Zoties

11.4.1 Zoties Company Details

11.4.2 Zoties Business Overview

11.4.3 Zoties Human DNA Vaccines Introduction

11.4.4 Zoties Revenue in Human DNA Vaccines Business (2019-2024)

11.4.5 Zoties Recent Developments

11.5 Elanco

11.5.1 Elanco Company Details

11.5.2 Elanco Business Overview

11.5.3 Elanco Human DNA Vaccines Introduction

11.5.4 Elanco Revenue in Human DNA Vaccines Business (2019-2024)

11.5.5 Elanco Recent Developments

11.6 Boehringer-Ingelheim

11.6.1 Boehringer-Ingelheim Company Details

11.6.2 Boehringer-Ingelheim Business Overview

11.6.3 Boehringer-Ingelheim Human DNA Vaccines Introduction

11.6.4 Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2019-2024)

11.6.5 Boehringer-Ingelheim Recent Developments

11.7 Indian Immunologicals

11.7.1 Indian Immunologicals Company Details

11.7.2 Indian Immunologicals Business Overview

11.7.3 Indian Immunologicals Human DNA Vaccines Introduction

11.7.4 Indian Immunologicals Revenue in Human DNA Vaccines Business (2019-2024)

11.7.5 Indian Immunologicals Recent Developments

11.8 Plumbline Life Sciences

11.8.1 Plumbline Life Sciences Company Details

11.8.2 Plumbline Life Sciences Business Overview

11.8.3 Plumbline Life Sciences Human DNA Vaccines Introduction

11.8.4 Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2019-2024)

11.8.5 Plumbline Life Sciences Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Indian Immunologicals

Plumbline Life Sciences

List of Tables

Table 1. Global Human DNA Vaccines Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Recombinant Protein Vaccine

Table 3. Key Players of Gene-Based Vaccine

Table 4. Global Human DNA Vaccines Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Human DNA Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Human DNA Vaccines Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Human DNA Vaccines Market Share by Region (2019-2024)

Table 8. Global Human DNA Vaccines Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Human DNA Vaccines Market Share by Region (2025-2030)

Table 10. Human DNA Vaccines Market Trends

Table 11. Human DNA Vaccines Market Drivers

Table 12. Human DNA Vaccines Market Challenges

Table 13. Human DNA Vaccines Market Restraints

Table 14. Global Human DNA Vaccines Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Human DNA Vaccines Revenue Share by Players (2019-2024)

Table 16. Global Top Human DNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human DNA Vaccines as of 2023)

Table 17. Global Human DNA Vaccines Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Human DNA Vaccines Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Human DNA Vaccines, Headquarters and Area Served

Table 20. Global Key Players of Human DNA Vaccines, Product and Application

Table 21. Global Key Players of Human DNA Vaccines, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Human DNA Vaccines Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Human DNA Vaccines Revenue Market Share by Type (2019-2024)

Table 25. Global Human DNA Vaccines Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Human DNA Vaccines Revenue Market Share by Type (2025-2030)

Table 27. Global Human DNA Vaccines Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Human DNA Vaccines Revenue Share by Application (2019-2024)

Table 29. Global Human DNA Vaccines Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Human DNA Vaccines Revenue Share by Application (2025-2030)

Table 31. North America Human DNA Vaccines Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Human DNA Vaccines Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Human DNA Vaccines Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Human DNA Vaccines Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Human DNA Vaccines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Human DNA Vaccines Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Human DNA Vaccines Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Human DNA Vaccines Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Human DNA Vaccines Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Human DNA Vaccines Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Human DNA Vaccines Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Human DNA Vaccines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Human DNA Vaccines Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Human DNA Vaccines Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Human DNA Vaccines Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Human DNA Vaccines Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Human DNA Vaccines Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Human DNA Vaccines Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Human DNA Vaccines Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Human DNA Vaccines Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Human DNA Vaccines Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Human DNA Vaccines Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Human DNA Vaccines Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Human DNA Vaccines Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Human DNA Vaccines Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Human DNA Vaccines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Human DNA Vaccines Market Size by Country (2025-2030) & (US$ Million)

Table 63. Merck Company Details

Table 64. Merck Business Overview

Table 65. Merck Human DNA Vaccines Product

Table 66. Merck Revenue in Human DNA Vaccines Business (2019-2024) & (US$ Million)

Table 67. Merck Recent Developments

Table 68. GSK Company Details

Table 69. GSK Business Overview

Table 70. GSK Human DNA Vaccines Product

Table 71. GSK Revenue in Human DNA Vaccines Business (2019-2024) & (US$ Million)

Table 72. GSK Recent Developments

Table 73. Sanofi Company Details

Table 74. Sanofi Business Overview

Table 75. Sanofi Human DNA Vaccines Product

Table 76. Sanofi Revenue in Human DNA Vaccines Business (2019-2024) & (US$ Million)

Table 77. Sanofi Recent Developments

Table 78. Zoties Company Details

Table 79. Zoties Business Overview

Table 80. Zoties Human DNA Vaccines Product

Table 81. Zoties Revenue in Human DNA Vaccines Business (2019-2024) & (US$ Million)

Table 82. Zoties Recent Developments

Table 83. Elanco Company Details

Table 84. Elanco Business Overview

Table 85. Elanco Human DNA Vaccines Product

Table 86. Elanco Revenue in Human DNA Vaccines Business (2019-2024) & (US$ Million)

Table 87. Elanco Recent Developments

Table 88. Boehringer-Ingelheim Company Details

Table 89. Boehringer-Ingelheim Business Overview

Table 90. Boehringer-Ingelheim Human DNA Vaccines Product

Table 91. Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2019-2024) & (US$ Million)

Table 92. Boehringer-Ingelheim Recent Developments

Table 93. Indian Immunologicals Company Details

Table 94. Indian Immunologicals Business Overview

Table 95. Indian Immunologicals Human DNA Vaccines Product

Table 96. Indian Immunologicals Revenue in Human DNA Vaccines Business (2019-2024) & (US$ Million)

Table 97. Indian Immunologicals Recent Developments

Table 98. Plumbline Life Sciences Company Details

Table 99. Plumbline Life Sciences Business Overview

Table 100. Plumbline Life Sciences Human DNA Vaccines Product

Table 101. Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2019-2024) & (US$ Million)

Table 102. Plumbline Life Sciences Recent Developments

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Human DNA Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Human DNA Vaccines Market Share by Type: 2023 VS 2030

Figure 3. Recombinant Protein Vaccine Features

Figure 4. Gene-Based Vaccine Features

Figure 5. Global Human DNA Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Human DNA Vaccines Market Share by Application: 2023 VS 2030

Figure 7. Influenza Case Studies

Figure 8. Human Papillomavirus Case Studies

Figure 9. HIV Case Studies

Figure 10. Human DNA Vaccines Report Years Considered

Figure 11. Global Human DNA Vaccines Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Human DNA Vaccines Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Human DNA Vaccines Market Share by Region: 2023 VS 2030

Figure 14. Global Human DNA Vaccines Market Share by Players in 2023

Figure 15. Global Top Human DNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human DNA Vaccines as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Human DNA Vaccines Revenue in 2023

Figure 17. North America Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Human DNA Vaccines Market Share by Type (2019-2030)

Figure 19. North America Human DNA Vaccines Market Share by Application (2019-2030)

Figure 20. North America Human DNA Vaccines Market Share by Country (2019-2030)

Figure 21. United States Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Human DNA Vaccines Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Human DNA Vaccines Market Share by Type (2019-2030)

Figure 25. Europe Human DNA Vaccines Market Share by Application (2019-2030)

Figure 26. Europe Human DNA Vaccines Market Share by Country (2019-2030)

Figure 27. Germany Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Human DNA Vaccines Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Human DNA Vaccines Market Share by Type (2019-2030)

Figure 35. China Human DNA Vaccines Market Share by Application (2019-2030)

Figure 36. Asia Human DNA Vaccines Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Human DNA Vaccines Market Share by Type (2019-2030)

Figure 38. Asia Human DNA Vaccines Market Share by Application (2019-2030)

Figure 39. Asia Human DNA Vaccines Market Share by Region (2019-2030)

Figure 40. Japan Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Human DNA Vaccines Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Human DNA Vaccines Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Human DNA Vaccines Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Human DNA Vaccines Market Share by Country (2019-2030)

Figure 50. Brazil Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Human DNA Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Merck Revenue Growth Rate in Human DNA Vaccines Business (2019-2024)

Figure 57. GSK Revenue Growth Rate in Human DNA Vaccines Business (2019-2024)

Figure 58. Sanofi Revenue Growth Rate in Human DNA Vaccines Business (2019-2024)

Figure 59. Zoties Revenue Growth Rate in Human DNA Vaccines Business (2019-2024)

Figure 60. Elanco Revenue Growth Rate in Human DNA Vaccines Business (2019-2024)

Figure 61. Boehringer-Ingelheim Revenue Growth Rate in Human DNA Vaccines Business (2019-2024)

Figure 62. Indian Immunologicals Revenue Growth Rate in Human DNA Vaccines Business (2019-2024)

Figure 63. Plumbline Life Sciences Revenue Growth Rate in Human DNA Vaccines Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions